Ackman Says Allergan Sale May Net $6B For Pershing Square

Bill Ackman said that his Pershing Square Capital Management LP could realize $6 billion when pharmaceutical company Allergan Inc. closes its sale to rival Actavis PLC, after his pressure led to the agreement to sell last week.